Correlation between pancreatic microcirculation and type 2 diabetes in patients with coronary artery disease: Dynamic contrast-enhanced MR imaging

Radiology

Volumn 252, Issue 3, 2009, Pages 704-711

  Yu, Chih Wei ^a,b   Shih, Tiffany Ting Fang ^a,b   Hsu, Chao Yu ^a,b   Lin, Lung Chun ^a   Wei, Shwu Yuan ^a   Lee, Chii Ming ^a   Lee, Yuan Teh ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GADODIAMIDE;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETIC PATIENT; DIAGNOSTIC IMAGING; FEMALE; HUMAN; IMAGING SYSTEM; MALE; MICROCIRCULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS BLOOD FLOW; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE;

AGED; AGED, 80 AND OVER; CONTRAST MEDIA; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MICROCIRCULATION; MIDDLE AGED; PANCREAS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS;

EID: 70349281585     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2523081615     Document Type: Article

References (41)

1. Bonner-Weir S, Orci L. New perspectives on the microvasculature of the islets of Langerhans in the rat. Diabetes 1982;31(10):883-889. (Pubitemid 12013792)
2. Henderson JR, Moss MC. A morphometric study of the endocrine and exocrine capillaries of the pancreas. Q J Exp Physiol 1985;70(3):347-356.
3. Olsson R, Carlsson PO. The pancreatic islet endothelial cell: emerging roles in islet function and disease. Int J Biochem Cell Biol 2006;38(5:-6):710-714. (Pubitemid 43363406)
4. Polonsky KS. Dynamics of insulin secretion in obesity and diabetes. Int J Obes Relat Metab Disord 2000;24(suppl 2):S29-S31. (Pubitemid 30461943)
5. Samols E, Stagner JI. Intra-islet regulation. Am J Med 1988;85(5A):31-35.
6. Brunicardi FC, Stagner J, Bonner-Weir S, et al. Microcirculation of the islets of Langerhans. Long Beach Veterans Administration Regional Medical Education Center Symposium. Diabetes 1996;45(4):385-392.
7. Svensson AM, Ostenson CG, Jansson L. Age-induced changes in pancreatic islet blood flow: evidence for an impaired regulation in diabetic GK rats. Am J Physiol Endocrinol Metab 2000;279(5):E1139-E1144.
8. Iwase M, Uchizono Y, Tashiro K, Goto D, Iida M. Islet hyperperfusion during prediabetic phase in OLETF rats, a model of type 2 diabetes. Diabetes 2002;51(8):2530-2535. (Pubitemid 34827403)
9. Carlsson PO, Andersson A, Jansson L. Influence of age, hyperglycemia, leptin, and NPY on islet blood flow in obese-hyperglycemic mice. Am J Physiol 1998;275(4 pt 1):E594-E601. (Pubitemid 128732047)
10. Mizuno A, Noma Y, Kuwajima M, Murakami T, Zhu M, Shima K. Changes in islet capillary angioarchitecture coincide with impaired B-cell function but not with insulin resistance in male Otsuka-Long-Evans-Tokushima fatty rats: dimorphism of the diabetic phenotype at an advanced age. Metabolism 1999;48(4):477-483.
11. Zanone MM, Favaro E, Camussi G. From endothelial to beta cells: insights into pancreatic islet microendothelium. Curr Diabetes Rev 2008;4(1):1-9. (Pubitemid 351210967)
12. Jansson PA. Endothelial dysfunction in insulin resistance and type 2 diabetes. J Intern Med 2007;262(2):173-183. (Pubitemid 47087632)
13. Abuissa H, Jones PG, Marso SP, O'Keefe JH Jr. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials. J Am Coll Cardiol 2005;46(5):821-826. (Pubitemid 41224805)
14. Leung PS, de Gasparo M. Involvement of the pancreatic renin-angiotensin system in insulin resistance and the metabolic syndrome. J Cardiometab Syndr 2006;1(3):197-203.
15. Thorand B, Baumert J, Chambless L, et al. Elevated markers of endothelial dysfunction predict type 2 diabetes mellitus in middle-aged men and women from the general population. Arterioscler Thromb Vasc Biol 2006;26(2):398-405. (Pubitemid 43732206)
16. Festa A, D'Agostino R Jr, Tracy RP, Haffner SM; Insulin Resistance Atherosclerosis Study. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 2002;51(4):1131-1137.
17. Meigs JB, O'Donnell CJ, Tofler GH, et al. Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study. Diabetes 2006;55(2):530-537. (Pubitemid 43343286)
18. Larsson HB, Stubgaard M, Frederiksen JL, Jensen M, Henriksen O, Paulson OB. Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn Reson Med 1990;16(1):117-131. (Pubitemid 20353802)
19. Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. I. Fundamental concepts. Magn Reson Med 1991;17(2):357-367.
20. Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997;7(1):91-101.
21. St Lawrence KS, Lee TY. An adiabatic approximation to the tissue homogeneity model for water exchange in the brain. II. Experimental validation. J Cereb Blood Flow Metab 1998;18(12):1378-1385. (Pubitemid 28559685)
22. Hylton N. Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. J Clin Oncol 2006;24(20):3293-3298. (Pubitemid 46622069)
23. Jackson A, O'Connor JP, Parker GJ, Jayson GC. Imaging tumor vascular heterogeneity and angiogenesis using dynamic contrast-enhanced magnetic resonance imaging. Clin Cancer Res 2007;13(12):3449-3459. (Pubitemid 46955104)
24. O'Connor JP, Jackson A, Parker GJ, Jayson GC. DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents. Br J Cancer 2007;96(2):189-195. (Pubitemid 46160619)
25. Leach MO, Brindle KM, Evelhoch JL, et al. The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. Br J Cancer 2005;92(9):1599-1610. (Pubitemid 40756468)
26. Hulka CA, Edmister WB, Smith BL, et al. Dynamic echo-planar imaging of the breast: experience in diagnosing breast carcinoma and correlation with tumor angiogenesis. Radiology 1997;205(3):837-842.
27. Hawighorst H, Weikel W, Knapstein PG, et al. Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome. Clin Cancer Res 1998;4(10):2305-2312. (Pubitemid 28477893)
28. Knopp MV, Weiss E, Sinn HP, et al. Pathophysiologic basis of contrast enhancement in breast tumors. J Magn Reson Imaging 1999;10(3):260-266. (Pubitemid 29463108)
29. Heverhagen JT, Wagner HJ, Ebel H, Levine AL, Klose KJ, Hellinger A. Pancreatic transplants: noninvasive evaluation with secretin-augmented MR pancreatography and MR perfusion measurements - preliminary results. Radiology 2004;233(1):273-280. (Pubitemid 39280984)
30. Hathout E, Sowers L, Wang R, et al. In vivo magnetic resonance imaging of vascularization in islet transplantation. Transpl Int 2007;20(12):1059-1065.
31. Coenegrachts K, Van Steenbergen W, De Keyzer F, et al. Dynamic contrast-enhanced MRI of the pancreas: initial results in healthy volunteers and patients with chronic pancreatitis. J Magn Reson Imaging 2004;20(6):990-997. (Pubitemid 39577901)
32. Obuz F, Dicle O, Coker A, Sagol O, Karademir S. Pancreatic adenocarcinoma: detection and staging with dynamic MR imaging. Eur J Radiol 2001;38(2):146-150. (Pubitemid 32396822)
33. Tajima Y, Kuroki T, Tsutsumi R, Isomoto I, Uetani M, Kanematsu T. Pancreatic carcinoma coexisting with chronic pancreatitis versus tumor-forming pancreatitis: diagnostic utility of the time-signal intensity curve from dynamic contrast-enhanced MR imaging. World J Gastroenterol 2007;13(6):858-865. (Pubitemid 46470295)
34. Bali MA, Metens T, Denolin V, De Maertelaer V, Deviere J, Matos C. Pancreatic perfusion: noninvasive quantitative assessment with dynamic contrast-enhanced MR imaging without and with secretin stimulation in healthy volunteers - initial results. Radiology 2008;247(1):115-121.
35. Austen WG, Edwards JE, Frye RL, et al. A reporting system on patients evaluated for coronary artery disease: report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovasc Surg, American Heart Association. Circulation 1975;51(4 suppl):5-40.
36. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983;51(3):606.
37. Chao CL, Tsai HH, Lee CM, et al. The graded effect of hyperhomocysteinemia on the severity and extent of coronary atherosclerosis. Atherosclerosis 1999;147(2):379-386. (Pubitemid 29512270)
38. Way KJ, Katai N, King GL. Protein kinase C and the development of diabetic vascular complications. Diabet Med 2001;18(12):945-959. (Pubitemid 34042930)
39. Avignon A, Sultan A. PKC-B inhibition: a new therapeutic approach for diabetic complications? Diabetes Metab 2006;32(3):205-213.
40. Kasaoka S, Okuda F, Satoh A, et al. Effect of coronary risk factors on coronary angiographic morphology in patients with ischemic heart disease. Jpn Circ J 1997;61(5):390-395. (Pubitemid 27242036)
41. Krishnaswami S, Jose VJ, Joseph G. Lack of correlation between coronary risk factors and CAD severity. Int J Cardiol 1994;47(1):37-43. (Pubitemid 24347748)